Hikal lost 7.29% to Rs 128.50 at 10:55 IST on BSE, after net profit declined 67.9% to Rs 1.83 crore on 0.6% growth in net sales to Rs 191.48 crore in Q1 June 2015 over Q1 June 2014.
The result was announced after market hours yesterday, 29 July 2015.
Meanwhile, the S&P BSE Sensex was up 212.54 points or 0.77% at 27,775.97
On BSE, so far 15,346 shares were traded in the counter as against average daily volume of 3,940 shares in the past one quarter.
The stock hit a high of Rs 134 and a low of Rs 125.30 so far during the day. The stock had hit a record high of Rs 167 on 2 January 2015. The stock had hit a 52-week low of Rs 101.87 on 8 August 2014.
The stock had outperformed the market over the past one month till 29 July 2015, rising 13.33% compared with Sensex's 0.3% decline. The scrip had also outperformed the market in past one quarter, gaining 2.36% as against Sensex's 1.24% gain.
Hikal partners companies in the pharmaceuticals, biotech, agrochemicals and specialty chemicals industries. It provides active ingredients, intermediates and R&D services and solutions.
Powered by Capital Market - Live News
